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Purpose: Numerous studies showed the effectiveness of pharmaceutical care in improving 
medication adherence in primary care patients. However, in daily pharmacy practice, the provi-
sion of pharmaceutical care appears to be limited. We aimed at quantifying the content of coun-
seling by community pharmacy staff during patient contacts, especially adherence counseling, 
and at investigating pharmacist views about their practice of adherence counseling.
Patients and methods: A Master’s student in Pharmacy observed patient contacts at selected 
community pharmacies in the region of Basel, Switzerland. Content of counseling was manu-
ally ticked on a checklist with predefined themes (administration, dose, effect, and adherence). 
Pharmacists working in the pharmacy were interviewed on triggers, topics, and barriers in 
adherence counseling.
Results: In 20 community pharmacies and during a total of 148.1 hours, 1,866 patient contacts 
were observed. During the 1,476 patient contacts including the dispensing of one or more medi-
cations, counseling was provided to 799 (54.1%) patients; with 735 (49.8%) patients counseled 
about administration, 362 (24.5%) about dose, 267 (18.1%) about effect, and 99 (6.7%) about 
adherence. Significantly more patients received counseling when they obtained prescribed 
versus over-the-counter medication (P=0.002), a new prescription versus a repeat prescription 
(P0.001), or when they were served by a pharmacist versus by another staff member (P0.001). 
Of the 33 interviewed pharmacists, all except one reported actively approaching patients for 
adherence counseling. Triggers included medication-related and patient-related factors. The 
pharmacists named predominantly product-centered topics of adherence counseling. The most 
cited barriers were rejection of counseling by the patient and lack of time.
Conclusion: Half of the patients receiving one or more medications were counseled, and only 
6.7% of all contacts included adherence counseling. Future studies should clarify how barriers 
to adherence counseling at the community pharmacy can be overcome.
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Introduction
Pharmaceutical care has been defined as “…the pharmacist’s contribution to the care 
of individuals in order to optimize medicines use and improve health outcomes,”1 and 
the pharmacist has been designated as part of the health care team for added value 
in the health care system.2–4 Pharmaceutical care activities practiced by community 
pharmacies have been shown effective in improving medication adherence.5–12 Face-
to-face counseling during dispensing of medication is part of pharmaceutical care.4 
Counseling can include providing education to patients (eg, about therapy, their 
condition), intervening in a patient’s drug therapy (eg, optimizing intake times), 
and ultimately, helping improve medication adherence.13 Previous studies reported 
significantly improved adherence and persistence through targeted counseling by 
community pharmacists.14–16
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Counseling practice in community pharmacies has 
been reported to be limited. In a pan-Europe comparison 
in 2009, the mean total score of pharmaceutical care provi-
sion, expressed as a percentage of the total score achiev-
able, ranged from 31.6% to 52.2%.17 Patient counseling 
was reported to be only a minor task in every day practice 
in the community pharmacy,18–21 and communication was 
predominantly nonmedical or product-centered, instead of 
patient-centered.22–24
At the dispensing of prescription medication, Swiss 
pharmacists are reimbursed for providing counseling on 
dose, frequency, administration, duration of use, storage, 
and potential adverse effects.25 Introduced in 2005, this was 
the first acknowledgment of cognitive services delivered 
by community pharmacists to improve the patients’ use of 
medication. Additionally, the provision of a dose-dispensing 
aid by the pharmacy is reimbursed.26
To our knowledge, the current counseling practices in 
Swiss community pharmacies have not yet been addressed, 
especially the content of adherence counseling. The aim 
of this study was to quantify the content of counseling by 
community pharmacy staff during patient contacts, with a 
specific focus on adherence counseling, and to investigate 
the views of community pharmacists about their practice of 
adherence counseling.
Material and methods
Of 106 community pharmacies in the region of Basel, 
Switzerland, community pharmacies that had participated in 
previous studies27,28 were approached consecutively, accord-
ing to a random number list, until the sample size of 20 was 
reached. This number was calculated to enable approximately 
2,000 patient contacts, assuming that counseling would take 5 
minutes and one investigator could observe approximately 100 
patients during 8 hours. We did not perform analysis of health 
communication between pharmacy staff and patients, but 
rather, we observed and quantified the content of counseling. 
A Master’s student in Pharmacy observed the patient contacts 
of the pharmacy staff in sequential order during 1 day at each 
pharmacy. The observation began at the entrance of one patient 
into the pharmacy and lasted until the departure of this patient; 
thereupon, the student observed the next patient who entered 
the pharmacy. Information about the staff member serving the 
patient, the number of dispensed medications, and content of 
counseling were manually ticked on a checklist. The checklist 
enabled ad hoc coding of the patient contacts by allocation into 
two categories (“medication on prescription” and “medica-
tion over the counter”), as well as the coding of four themes 
(“administration”, “dose”, “effect”, and “adherence”) and 12 
topics of adherence counseling. The latter were deduced from 
published recommendations (Table 1).29 Observation time and 
characteristics of the pharmacy and the team were simultane-
ously assessed. At the end of the observation time, an interview 
was performed with all present pharmacists, consisting of two 
closed-ended questions (active approach to patients about 
adherence [yes/no]; frequency of active approach per month) 
and three open-ended questions (triggers, topics, and barriers 
in adherence counseling).
We defined explicit adherence counseling as provision 
of patient-centered information that directly addresses the 
spectrum of adherence problems, including unintentional 
(ie, the patient is physically or cognitively unable to adhere) 
and intentional nonadherence (ie, the patient is not willing 
to adhere); this included the use of targeted questioning 
(“have you missed any pills in the past week”), offer of refill 
reminders and dose-dispensing aids, reinforcement, etc.29 
We defined implicit adherence counseling as provision of 
product-centered information, eg, information on adminis-
tration or dose. This information does not directly address 
adherence but might prevent unintentional nonadherence.
Coded patient contacts were quantified and analyzed 
statistically within the sample of patients obtaining one or 
more medications. Answers from the interviews were cat-
egorized and analyzed quantitatively. We used SPSS V. 20 
(IBM Corp., Armonk, NY, USA) for Windows for descriptive 
and comparative (χ2-test) calculations. A P-value of 0.05 
was considered statistically significant. Missing data were 
excluded from analysis.
Results
During February and March 2010, 21 community pharmacies 
were approached, 20 took part in the study, and one pharmacy 
declined participation without specification of a reason. The 
pharmacies were located in the city center (eight), in resi-
dential districts (eight), and in shopping centers (four). Of a 
median of 9.25 opening hours (range 8.75–11.5), 7.5 hours 
(range 6.5–7.75) were observed per day and pharmacy. The 
observation day was equally distributed over the weekdays 
(Tuesday [five]; Monday, Wednesday, and Thursday [four]; 
and Friday [three]). The median number of working staff 
members was two pharmacists, three pharmacy technicians, 
and one apprentice, respectively.
During the total observation time of 148.1 hours, 1,866 
patient contacts were observed, of which 21 resulted in a 
referral to the physician, 18 in further inquiry by phone or 
fax with the physician, and eight in a refusal of dispensing. 
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A total of 1,476 patient contacts included the dispensing of 
one or more medications, constituting the basis sample for 
statistical analysis (Figure 1). Of 2,789 products dispensed, 
1,742 (62.5%) were on prescription and 1,047 (37.5%) were 
“over the counter” (OTC). Counseling was provided to 799 
(54.1%) patients, with 735 (49.8%) patients counseled about 
administration, 362 (24.5%) about dose, 267 (18.1%) about 
effect, and 99 (6.7%) about adherence (Figure 2). The total 
number of observed counseling events was 1,800, with 
most patients receiving counseling on two (55.4%) or three 
(21.2%) themes. Explicit adherence counseling (n=130) 
mostly included comprehensive instruction (49 [37.7%]) 
and counseling on knowledge of disease and medication 
(36 [27.7%]) (Table 1). Significantly more patients solely 
obtaining prescription medication were provided with overall 
counseling compared with those solely obtaining OTC medica-
tion (57.3% vs 50.2%) (χ2=7.1, P=0.002; n=1,402). In the same 
groups, the single theme “effect” was observed significantly 
more often in patients contacts with the dispensing of OTC 
than in patients contacts with the dispensing of prescription 
medication (31.3% vs 6.3%) (χ2=148.3, P0.001; n=1,402). 
There was no significant difference in frequency of adherence 
counseling for prescription vs OTC medication (7.1% vs 5.9%) 
(χ2=0.9, P=0.17; n=1,402).
Focusing on the 757 patients solely receiving prescription 
medication, 421 (55.6%) had a new prescription, 293 (38.7%) 
requested a repeat prescription, 26 (3.4%) had both, and 
17 (2.2%) were not specified (Figure 1). The pharmacy staff 
provided overall counseling to significantly more patients 
with new prescriptions compared with patients with repeat 
prescriptions (74.1% vs 33.8%) (χ2=115.0, P0.001; n=714). 
There was no significant difference in frequency of adherence 
counseling in these two groups (new vs repeat prescriptions: 
7.1% vs 4.4%, respectively) (χ2=2.2, P=0.14).
Table 1 Definitions and numbers of observed counseling events by counseling themes and topics of explicit adherence counseling
Counseling theme Definition Numbers of observed  
counseling
Prescription OTC
Administration counseling on basic administration issues (eg, with respect  
to meals)
435 317
Dose counseling on dosage, dosing times, intervals, and duration  
of medication therapy
418 226
effect counseling about the effects of the medication 53 221
Adherence explicit adherence counseling according to the list of topics 73 57
Topics of explicit adherence counseling
Morisky question Asking the explicit question: “Do you ever forget to  
take your medication?”
0 0
Adherence Directly addressing adherence; assessing the patient’s  
attitude towards adherence; and mentioning  
the importance of adherence
8 2
Positive reinforcement Acknowledging and encouraging the patients on  
efforts for adherent behavior
2 0
Motivation Assessing motivation of patient to be adherent and,  
if necessary, providing support
2 2
Organization Offering facilitation of medication management through  
stick-on labels, diaries, timers, dose-dispensing aids, phone  
reminders, organization of social support, etc
9 2
Appointment keeping reminding the patient of appointments (with physician,  
refill, monitoring)
1 1
Psychological barriers Among others: forgetfulness; fear of side effects 3 0
Physical barriers Among others: impaired vision and dexterity; difficulties with swallowing 4 0
instruction of product Providing comprehensive verbal information on use  
of the medication in the context of adherence
31 18
Written information Providing written information on the medication 2 5
Knowledge about  
disease/therapy
explaining the relation between medication therapy  
and disease/necessity of therapeutic intervention
10 26
(self-) monitoring instructing the patient about how to perform (self-) monitoring,  
including instruction on interpretation of monitored parameters
1 1
Abbreviation: OTc, over the counter.
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Of all patients receiving one or more medications 
(n=1,476), 368 (24.9%) were served by a pharmacist, 1,075 
(72.8%) by another staff member (eg, pharmacy technician 
or apprentice), and 33 (2.2%) by a combination of both. Sig-
nificantly more patients received counseling when they were 
served by a pharmacist compared with other staff members 
(62.1% vs 51.2%) (χ2=14.1, P0.001). Adherence counsel-
ing was provided to twice as many patients when served by 
a pharmacist compared with other staff members (10.7% vs 
5.2%) (χ2=14.2, P0.001).
Of 390 patients who did not receive a medication at the 
observed contact (eg, buying dose-dispensing aids, ordering 
out-of-stock medication), 42 (10.8%) received counseling.
interview
Among the 20 community pharmacies, 33 pharmacists par-
ticipated in the interview (a median of two and range of one 
to three pharmacists per pharmacy) and were mainly women 
(69.7%), with a median age of 41 (range 25–68) years and 
a median duration of 14 (range 1–43) years after university 
graduation. They worked with a median of 90% employment 
at the community pharmacy (range 40%–100%). All phar-
macists except one reported actively asking patients about 
their adherence, and 20 (60.6%) did so on a daily basis. 
Figures 3 and 4 illustrate named triggers and topics of adher-
ence counseling. Barriers included rejection by the patient 
(15 [45.5%]), lack of time (12 [36.4%]), lack of patient data 
(seven [21.2%]), lack of checklists and demo material (six 
[18.2%]), lack of confidential room (five [15.2%]), lack of 
remuneration (three [9.1%]), and “Other” (19 [57.6%]).
Discussion
Counseling was provided to half of the patients receiving one or 
more medications and occurred more frequently when the medi-
cation was on prescription, on a new prescription, or if patients 
were served by a pharmacist. The content of the counseling 
mostly included information on medication administration and 
dose. Only 6.7% of the patients obtaining medication received 
explicit adherence counseling, significantly more of them if 
the pharmacist was involved in the dispensing. However, most 
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Figure 3 Triggers to start adherence counseling named by 31 pharmacists.
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pharmacists seemed motivated to provide adherence counseling. 
They named a lot of triggers but also barriers to start adherence 
counseling and mostly named topics for adherence counseling, 
which only implicitly addressed the issue.
Due to easy access, regular patient visits, the possibility to 
monitor medication refill frequency, and the competences of 
the pharmacist, the community pharmacy seems to be a predes-
tined place for counseling about adherence. In our study, we 
showed that if pharmacy staff counseled, they counseled about 
more than one theme, indicating motivation and assumption of 
responsibility for safe and effective medication management. 
If only looking at prescription medication, unsurprisingly, 
dispensing of first prescriptions largely predominated in the 
number of patients provided with counseling. A considerable 
percentage (74.1%) of these patients were counseled. Apart 
from the need to ensure the patient’s knowledge at first use, 
the patient filling a first prescription also seems to expect more 
counseling, which might result in facilitating counseling.30 
Still, explicit adherence counseling accounts for a very small 
part in both situations, in the dispensing of a new prescrip-
tion and in the dispensing of a repeat prescription. Because 
the pharmacist is able to detect nonadherence in patients 
with long-term therapy, eg, by analyzing medication refill 
frequency, we expected adherence counseling to occur more 
in patients with repeat prescriptions.
Evidence that community pharmacy interventions have 
been successful in improving health outcomes and adher-
ence have accumulated,5–10,12,31–34 and two Cochrane reviews 
concluded that the pharmacists’ cognitive services were 
beneficial for safe and effective medication use.3,11 However, 
our study confirms results of earlier studies showing that 
community pharmacies provided limited pharmaceutical care 
services,17,19,35–37 indicating a problem of implementation in 
daily practice. Studies on counseling in community pharma-
cies were conducted using patient and pharmacist surveys, 
observation, and simulated patient visits.38,39 They mostly 
reported on pharmacists’ behavior only, with a total counsel-
ing rate of 8%–100%.39 Similar to our study, predominant 
categories of counseling were administration and dose, 
and hence were more product- than patient-centered.22–24,39 
A large proportion of communications (26%–40%) between 
pharmacists and patients was reported to be nonmedical.36,37 
The only observational study specifically investigating 
adherence counseling was performed with pharmacy stu-
dents, who had a lack of specific training in adherence 
management and of resources, and therefore reported not 
to address adherence in counseling sessions.40 A German 
study showed that pharmacists documented “evidence of 
nonadherence” in only 1.6% of all assessed drug-related 
problems during patient contacts in community pharmacies, 
Figure 4 Topics of adherence counseling named by 33 pharmacists.
Notes: The topics marked with asterisks correspond to the predefined topics of explicit adherence counseling in Table 1.
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indicating that the pharmacists had difficulties in identifying 
nonadherence.41
We showed that pharmacists provided more counseling 
than pharmacy staff, which confirms the results of another 
study.35 Differences may arise from the more detailed 
knowledge about therapy and disease, more intense training, 
and from the assumption of the responsibility for safe and 
effective medication use by the patients. This knowledge 
and attitude, however, should be transferred to the whole 
pharmacy team.
In our study, the comparison of observed counseling 
practice (observed adherence counseling of 6.7%) with 
pharmacists’ interview responses (60.6% indicated actively 
approaching patients with adherence issues every day) 
reveals a discrepancy between our definition and the phar-
macists’ opinions about the topics of adherence counseling. 
We defined the topics more explicitly, whereas the most 
frequently named topics by the pharmacists were implicit. 
Several problems could arise from the implicit approach. 
First, the patients might not understand the purpose of the 
counseling and reject it. Second, while some unintentional 
nonadherence problems might be clarified with counseling 
on administration and dose, intentional nonadherence might 
be completely overlooked. Literature has described habits of 
pharmacists mainly asking standardized questions, eg, “Do 
you have any questions?”; at the same time, authors have 
suggested a more considerate and individualized approach 
according to patients’ needs, and the necessity of engaging 
patients in counseling.24,42,43 Such an approach would include 
a more direct addressing of adherence. Further, almost all 
topics on our predefined list of explicit adherence counsel-
ing were named by the pharmacists, indicating that they 
were familiar with most of the topics, though less frequently 
addressed them during the observed patient contacts.
The most frequently reported barrier was rejection of the 
offered counseling by the patients. This has also been shown 
in other studies, with 41%–63% of patients declining offered 
counseling.30,36 Expectations of patients have been shown to 
not coincide with the recent development of the pharmacist’s 
role.43,44 Qualitative studies reported patient tendency to rely 
solely on the physicians, recommendations and to deny the 
pharmacists’ competences.45,46 This attitude persisted even 
in patient-centered consultations47 and was confirmed by a 
recent study that collected data over 15 years.48
It seems logical that patients with prescribed medications 
obtain more counseling, on one hand because the medication 
plan usually is more complex, including long- and short-term 
medication for serious diseases, and hence counseling might 
be more relevant. On the other hand, the counseling about 
prescribed medication is remunerated by a medication tax of 
CHF 4.20 (= US$ 4.60) per prescribed item. Nevertheless, 
lack of adequate remuneration was only named by 9.1% of the 
pharmacists as barrier for adherence counseling. Remarkably, 
counseling was also given without product sale.
Apart from the structural factors discussed above, several 
procedure-related factors were identified, which hinder phar-
macists in counseling, and patients in asking questions. Time 
constraints pose such a barrier.40,48–50 However, surveys on 
pharmacists’ activities revealed that pharmacists were mainly 
occupied with traditional product-centered activities, such as 
business management, logistics, and product assembly, than 
with patient-centered activities, like counseling.18–21 In our 
study, we observed that pharmacists had fewer patient con-
tacts in relation to their presence compared with the rest of 
the staff. Consequently, the problem could be designated as 
time mismanagement, and reconsiderations of staffing and 
of assignment of responsibilities might be a solution.
Another barrier to patient-centered, individualized 
counseling is the lack of privacy, named by the pharmacists 
in our study and also reported elsewhere.35,45,50 Most people 
certainly are uncomfortable discussing their sensitive health 
problems next to a line of others at the counter. The traditional 
conceptualization of the pharmacy accommodations reminds 
patients more of a shop46 than of a health care center and 
hence is not supportive in promoting counseling.
The limitations of our study firstly include the restriction 
to one region in Switzerland. Secondly, the methodology of 
observation has been reported to yield variable results but 
a more holistic picture of counseling practice.39 We chose 
a minimally obtrusive method to observe the counseling, 
in order to prevent the introduction of biases. However, 
the open approach of the pharmacies and the presence of 
an observer could have triggered pharmacy staff to engage 
more in counseling practice than usual (Hawthorne effect).51 
Thirdly, the ad hoc coding without review by a second person 
could have limited the results’ reliability. Fourthly, due to 
the observational setting, we could not evaluate the rate of 
overall offered counseling. With the most named barrier for 
adherence counseling being the rejection of counseling by 
the patients, we can assume higher counseling rates at higher 
acceptance of counseling.
Conclusion
The unique position of the community pharmacy in the health 
care chain and the competencies of pharmacists make the 
community pharmacy a predestined place for medication and 
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adherence counseling. Pharmacists are motivated to provide 
counseling but experience several structural and procedural 
barriers in delivering it. In our study, half of patients col-
lecting one or more medications received counseling, which 
was predominantly product-centered, and only 6.7% of the 
patients received adherence counseling. This study revealed 
insufficient knowledge and gaps in the provision of explicit 
adherence counseling by pharmacists. Future studies should 
explore the pharmacist–patient interaction in depth and 
clarify how barriers to adherence counseling in the com-
munity pharmacy can be overcome.
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